Trial intelligence / Profile preview

Dexmedetomidine IV vs Peribulbar for Strabismus Surgery

NCT05215158Completed

Sponsor
Aswan University Hospital
Start
Jan 2022
Primary completion
Jul 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of dexmedetomidine in strabismus (2 arms), sponsored by Aswan University Hospital. Primary endpoint: Duration of analgesia at 12 hours. Started Jan 2022; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

strabismus

Beyond the preview

Go deeper on NCT05215158.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05215158.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call